128 related articles for article (PubMed ID: 10660199)
1. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.
Broerse JJ; Snijders-Keilholz A; Jansen JT; Zoetelief J; Klein C; Seegenschmiedt MH
Radiother Oncol; 1999 Dec; 53(3):205-8. PubMed ID: 10660199
[TBL] [Abstract][Full Text] [Related]
2. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ
Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428
[TBL] [Abstract][Full Text] [Related]
3. [Radiotherapy for Graves' ophthalmopathy].
Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
[TBL] [Abstract][Full Text] [Related]
4. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy.
Akmansu M; Dirican B; Bora H; Gurel O
Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842
[TBL] [Abstract][Full Text] [Related]
5. Orbital irradiation in the treatment of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Panicucci M; Bogazzi F; Pinchera A
Bull Soc Belge Ophtalmol; 1988; 226():71-83. PubMed ID: 3151769
[No Abstract] [Full Text] [Related]
6. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region.
Verellen D; Vanhavere F
Radiother Oncol; 1999 Dec; 53(3):199-203. PubMed ID: 10660198
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience of radiation therapy for Graves' ophthalmopathy.
Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
[TBL] [Abstract][Full Text] [Related]
9. [The role of radiotherapy in Graves' ophthalmopathy].
Jaulerry C
J Fr Ophtalmol; 2004 Sep; 27(7):825-7. PubMed ID: 15499286
[TBL] [Abstract][Full Text] [Related]
10. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
[TBL] [Abstract][Full Text] [Related]
11. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy.
Schaefer U; Hesselmann S; Micke O; Schueller P; Bruns F; Palma C; Willich N
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):192-7. PubMed ID: 11777638
[TBL] [Abstract][Full Text] [Related]
12. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
[TBL] [Abstract][Full Text] [Related]
14. Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Exp Clin Endocrinol; 1991 May; 97(2-3):332-7. PubMed ID: 1915652
[No Abstract] [Full Text] [Related]
15. [Retrobulbar irradiation of endocrine ophthalmopathy: a comparison between 10 and 16 Gy total dose].
Pfluger T; Wendt T; Toroutoglou N; Pickardt C; Wuttge R
Strahlenther Onkol; 1990 Oct; 166(10):673-7. PubMed ID: 2237752
[TBL] [Abstract][Full Text] [Related]
16. Orbital radiotherapy for Graves' ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
[TBL] [Abstract][Full Text] [Related]
17. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
18. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy.
Blank LE; Barendsen GW; Prummel MF; Stalpers L; Wiersinga W; Koornneel L
Radiother Oncol; 1996 Aug; 40(2):187-9. PubMed ID: 8884975
[No Abstract] [Full Text] [Related]
19. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters.
Gerding MN; Prummel MF; Wiersinga WM
Clin Endocrinol (Oxf); 2000 May; 52(5):641-6. PubMed ID: 10792345
[TBL] [Abstract][Full Text] [Related]
20. Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy.
Robertson DM; Buettner H; Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Arch Ophthalmol; 2003 May; 121(5):652-7. PubMed ID: 12742842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
